DETROIT - The number of hepatitis C patients suffering from advanced
liver damage may be grossly underestimated and underdiagnosed, according
to a study led by researchers at Henry Ford Health System and the U.S.
Centers for Disease Control and Prevention.
The findings were the result of a study of nearly 10,000 patients
suffering from hepatitis C, and could have a significant effect on
patient care and healthcare policy regarding the chronic disease.
"Knowledge of the prevalence of liver damage will help decision
making regarding screening for the effects of hepatitis C, when to start
anti-viral therapy, and the need for follow-up counseling," says Stuart
Gordon, M.D., lead researcher and Director of Hepatology at Henry Ford
Labels: Chronic Hepatitis Cohort Study, Epidemiology, hidden disease, statistics